Dr. Lawrence Korngut – MD, FRCPC, CSCN (EMG)

Assistant Professor of Neurology – Calgary University, Neuromuscular Clinic

Dr. Korngut is a Clinical Assistant Professor, at the University of Calgary’s Department of Clinical Neurosciences, Hotchkiss Brain Institute. ​His research includes phase II and III clinical trials of new therapies for neuromuscular conditions. Dr. Korngut is also the Director of the Calgary ALS and Motor Neuron Disease Clinic, and is the Chair of the Medical and Scientific Advisory Committee for Muscular Dystrophy Canada. He is the National Principal Investigator of the Canadian Neuromuscular Disease Registry that now includes 31 participating clinics and over the past two years has recruited over 2000 patients.

In 2012-13, Dr. Korngut led a team of registry leaders and disease experts in developing the Canadian Neurological Registry Best Practice Guidelines that are accompanied by an implementation toolkit. The project culminated in the formation of the Canadian Registry Network.

In 2014, Dr. Korngut and colleagues obtained funding from the Canadian Institutes of Health Research and Muscular Dystrophy Canada to develop and launch the Canadian Neuromuscular Network (CAN-NMD), a nationwide collaboration of researchers, clinicians, and allied health professionals aiming to improve the lives of those affected by neuromuscular conditions through improving clinical care, research capacity and education.

    Dr. Lawrence Korngut – MD, FRCPC, CSCN (EMG)

    Assistant Professor of Neurology – Calgary University, Neuromuscular Clinic

    Dr. Korngut is a Clinical Assistant Professor, at the University of Calgary’s Department of Clinical Neurosciences, Hotchkiss Brain Institute. ​His research includes phase II and III clinical trials of new therapies for neuromuscular conditions. Dr. Korngut is also the Director of the Calgary ALS and Motor Neuron Disease Clinic, and is the Chair of the Medical and Scientific Advisory Committee for Muscular Dystrophy Canada. He is the National Principal Investigator of the Canadian Neuromuscular Disease Registry that now includes 31 participating clinics and over the past two years has recruited over 2000 patients.

    In 2012-13, Dr. Korngut led a team of registry leaders and disease experts in developing the Canadian Neurological Registry Best Practice Guidelines that are accompanied by an implementation toolkit. The project culminated in the formation of the Canadian Registry Network.

    In 2014, Dr. Korngut and colleagues obtained funding from the Canadian Institutes of Health Research and Muscular Dystrophy Canada to develop and launch the Canadian Neuromuscular Network (CAN-NMD), a nationwide collaboration of researchers, clinicians, and allied health professionals aiming to improve the lives of those affected by neuromuscular conditions through improving clinical care, research capacity and education.